Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma

30 Jul 2020

Abstract excerpt

Gastric adenocarcinoma (GAC) is the most common histological type of gastric cancer, the fifth according to the frequency and the third among the deadliest cancers. GAC high mortality is due to a combination of factors, such as silent evolution, late clinical presentation, underlying genetic heterogeneity, and effective mechanisms of chemoresistance (MOCs) that make the available antitumor drugs scarcely useful....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Colorectal Cancer Treatments and Studies
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32751679
DOI: 10.3390/cancers12082116

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric AdenocarcinomaPMID 32751679Read ↗

Portrayal of the complex molecular landscape of multidrug resistance in gastric cancer: Unveiling the potential targetsSemantic proximity Read ↗

Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer CellsSemantic proximity Read ↗

Drug resistance mechanisms in cancers: Execution of pro-survival strategiesSemantic proximity Read ↗

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug ResistanceSemantic proximity Read ↗

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal CancerSemantic proximity Read ↗

Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of AutophagySemantic proximity Read ↗

Identifying therapeutic targets in gastric cancer: the current status and future direction.Semantic proximity Read ↗

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor ProgressionSemantic proximity Read ↗

Molecular Mechanisms for Targeting Metastatic Cancer Cells and to Overcome or Prevent Chemotherapy ResistanceSemantic proximity Read ↗

The paradigm of drug resistance in cancer: an epigenetic perspectiveSemantic proximity Read ↗

Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical ApplicationsSemantic proximity Read ↗

Emerging actionable targets to treat therapy-resistant colorectal cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.